Cat.#: ACPP-1642
| Despition | ENPP2 Blocking Peptide |
| SIZE | 250 µg |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1385 | Human TGFBI Protein (AC1385) | 5 µg | inquiry |
| ACPP-1510 | Human TIMP1 Protein, Sf9 (AC1510) | 2 µg | inquiry |
| ACPP-1277 | TSH beta Blocking Peptide (AC1277) | 250 µg | inquiry |
| ACPP-1564 | Human EIF3K Protein (AC1564) | 2 µg | inquiry |
| ACPP-1085 | Recombinant Human alpha Internexin Protein (AC1085) | 25 µl | inquiry |
| ACPP-1650 | Human HSPB8 Protein (AC1650) | 2 µg | inquiry |
| ACPP-1638 | Human CNTF Protein (AC1638) | 5 µg | inquiry |
| ACPP-1009 | Recombinant Human TYRO3 Protein (6×His Tag) (AC1009) | 50 µg | inquiry |
| ACPP-1230 | MC3 Receptor Blocking Peptide (AC1230) | 250 µg | inquiry |
| ACPP-1836 | Human CHGA Protein (AC1836) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.